Short-Course, High-Dose Rifampicin Achieves <i>Wolbachia</i> Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis


Aljayyoussi, Ghaith, Tyrer, Hayley E, Ford, Louise, Sjoberg, Hanna, Pionnier, Nicolas, Waterhouse, David, Davies, Jill, Gamble, Joanne ORCID: 0000-0001-7302-3412, Metugene, Haelly, Cook, Darren AN et al (show 12 more authors) (2017) Short-Course, High-Dose Rifampicin Achieves <i>Wolbachia</i> Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis. SCIENTIFIC REPORTS, 7 (1). 210-.

[img] Text
Short course Rif Sci Rep.pdf - Published version
Download (1MB)

Abstract

Lymphatic filariasis (LF) and onchocerciasis are priority neglected tropical diseases targeted for elimination. The only safe drug treatment with substantial curative activity against the filarial nematodes responsible for LF (Brugia malayi, Wuchereria bancrofti) or onchocerciasis (Onchocerca volvulus) is doxycycline. The target of doxycycline is the essential endosymbiont, Wolbachia. Four to six weeks doxycycline therapy achieves >90% depletion of Wolbachia in worm tissues leading to blockade of embryogenesis, adult sterility and premature death 18-24 months post-treatment. Long treatment length and contraindications in children and pregnancy are obstacles to implementing doxycycline as a public health strategy. Here we determine, via preclinical infection models of Brugia malayi or Onchocerca ochengi that elevated exposures of orally-administered rifampicin can lead to Wolbachia depletions from filariae more rapidly than those achieved by doxycycline. Dose escalation of rifampicin achieves >90% Wolbachia depletion in time periods of 7 days in B. malayi and 14 days in O. ochengi. Using pharmacokinetic-pharmacodynamic modelling and mouse-human bridging analysis, we conclude that clinically relevant dose elevations of rifampicin, which have recently been determined as safe in humans, could be administered as short courses to filariasis target populations with potential to reduce anti-Wolbachia curative therapy times to between one and two weeks.

Item Type: Article
Uncontrolled Keywords: Animals, Humans, Mice, Filarioidea, Brugia malayi, Onchocerca volvulus, Wuchereria bancrofti, Wolbachia, Elephantiasis, Filarial, Onchocerciasis, Disease Models, Animal, Rifampin, DNA, Bacterial, Anti-Bacterial Agents, Treatment Outcome, Administration, Oral, Embryonic Development
Depositing User: Symplectic Admin
Date Deposited: 04 Feb 2019 10:39
Last Modified: 12 Oct 2023 17:56
DOI: 10.1038/s41598-017-00322-5
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3006645
Dimensions
Altmetric
CORE (COnnecting REpositories)